....continued from part one

 Almeida A, et al.           
A rapid method for the isolation of metabolically active mitochondria from rat
neurons and astrocytes in primary culture.
Brain Res Brain Res Protoc. 1998 Mar; 2(3): 209-214.
PMID: 9507134; UI: 98176023.

 Okada T, et al.           
Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through
dopamine transporter expressed in HEK293 cells.
Neurosci Res. 1998 Jan; 30(1): 87-90.
PMID: 9572583; UI: 98232296.

 Kaur H, et al.           
Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue.
J Neurochem. 1998 May; 70(5): 2220-2223.
PMID: 9572312; UI: 98232023.

 Fischel-Ghodsian N.           
Mitochondrial genetics and hearing loss: the missing link between genotype and
phenotype.
Proc Soc Exp Biol Med. 1998 May; 218(1): 1-6. Review.
PMID: 9572147; UI: 98231857.

 Molina JA, et al.           
The role of nitric oxide in neurodegeneration. Potential for pharmacological
intervention.
Drugs Aging. 1998 Apr; 12(4): 251-259.
PMID: 9571390; UI: 98232881.

 Levy G.           
Predicting effective drug concentrations for individual patients. Determinants
of pharmacodynamic variability.
Clin Pharmacokinet. 1998 Apr; 34(4): 323-333.
PMID: 9571304; UI: 98232795.

 Corrigan FM, et al.           
Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's
disease.
Exp Neurol. 1998 Apr; 150(2): 339-342.
PMID: 9527905; UI: 98197150.

 Palfi S, et al.           
MRI-Stereotactical approach for neural grafting in basal ganglia disorders.
Exp Neurol. 1998 Apr; 150(2): 272-281.
PMID: 9527897; UI: 98197142.

 Hawkes CH, et al.           
Olfactory disorder in motor neuron disease.
Exp Neurol. 1998 Apr; 150(2): 248-253.
PMID: 9527894; UI: 98197139.

 Duty S, et al.           
Topographical organization of opioid peptide precursor gene expression
following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned
Rat.
Exp Neurol. 1998 Apr; 150(2): 223-234.
PMID: 9527891; UI: 98197136.

 Gold M, et al.           
Plasma thiamine deficiency associated with Alzheimer's disease but not
Parkinson's disease.
Metab Brain Dis. 1998 Mar; 13(1): 43-53.
PMID: 9570639; UI: 98230566.

 Savitz DA, et al.           
Electrical occupations and neurodegenerative disease: analysis of U.S.
mortality data.
Arch Environ Health. 1998 Jan; 53(1): 71-74.
PMID: 9570311; UI: 98230237.

 Khisti RT, et al.           
Haloperidol-induced catalepsy: a model for screening antidepressants effective
in treatment of depression with Parkinson's disease.
Indian J Exp Biol. 1997 Dec; 35(12): 1297-1301.
PMID: 9567763; UI: 98229181.

 Friedman J.           
Olanzapine in the treatment of dopaminomimetic psychosis in patients with
Parkinson's disease.
Neurology. 1998 Apr; 50(4): 1195-1196. No abstract available.
PMID: 9566437; UI: 98226088.

 Jimenez-Jimenez FJ, et al.           
Olanzapine can worsen parkinsonism.
Neurology. 1998 Apr; 50(4): 1183-1184. No abstract available.
PMID: 9566425; UI: 98226076.

 Bennett P, et al.           
Absence of the G209A mutation in the alpha-synuclein gene in British families
with Parkinson's disease.
Neurology. 1998 Apr; 50(4): 1183. No abstract available.
PMID: 9566424; UI: 98226075.

 Marder K, et al.           
Postmenopausal estrogen use and Parkinson's disease with and without dementia.
Neurology. 1998 Apr; 50(4): 1141-1143.
PMID: 9566410; UI: 98226061.

 Marder K, et al.           
Systemic iron metabolism and mortality from Parkinson's disease.
Neurology. 1998 Apr; 50(4): 1138-1140.
PMID: 9566409; UI: 98226060.

 Chan P, et al.           
Absence of mutations in the coding region of the alpha-synuclein gene in
pathologically proven Parkinson's disease.
Neurology. 1998 Apr; 50(4): 1136-1137.
PMID: 9566408; UI: 98226059.

 Hoang TQ, et al.           
Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of
Huntington's and Parkinson's diseases.
Neurology. 1998 Apr; 50(4): 1033-1040.
PMID: 9566391; UI: 98226042.

 Agid Y.           
Levodopa: is toxicity a myth?
Neurology. 1998 Apr; 50(4): 858-863. Review.
PMID: 9566363; UI: 98226014.

 [No authors listed]           
Early selegiline treatment in Parkinson's disease may not be advantageous.
BMJ. 1998 Apr 18; 316(7139): A. No abstract available.
PMID: 9553031; UI: 98221079.

 Stone M.           
Jumbo gene offers clue to Parkinson's.
Science. 1998 Apr 10; 280(5361): 203. No abstract available.
PMID: 9565530; UI: 98225995.

 Muller T, et al.           
Selegilien as immunostimulant--a novel mechanism of action?
J Neural Transm Suppl. 1998; 52: 321-328.
PMID: 9564633; UI: 98225821.

 Sterling J, et al.           
(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective
and potent inhibitors of monoamine oxidase B.
J Neural Transm Suppl. 1998; 52: 301-305.
PMID: 9564630; UI: 98225818.

 Gotz ME, et al.
Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A
and B in the brain of the common marmoset.
J Neural Transm Suppl. 1998; 52: 271-278.
PMID: 9564627; UI: 98225815.

 Magyar K, et al.           
The neuroprotective and neuronal rescue effects of (-)-deprenyl.
J Neural Transm Suppl. 1998; 52: 109-123.
PMID: 9564614; UI: 98225801.

 Hocherman S, et al.           
Deprenyl monotherapy improves visuo-motor control in early parkinsonism.
J Neural Transm Suppl. 1998; 52: 63-69.
PMID: 9564608; UI: 98225795.

 Fahn S, et al.           
Experience with tranylcypromine in early Parkinson's disease.
J Neural Transm Suppl. 1998; 52: 49-61.
PMID: 9564607; UI: 98225794.

 Berns GS, et al.           
A computational model of how the basal ganglia produce sequences.
J Cogn Neurosci. 1998 Jan; 10(1): 108-121.
PMID: 9526086; UI: 98195446.

 Brannan T, et al.           
Effects of repeated administration of l-DOPA and apomorphine on circling
behavior and striatal dopamine formation.
Brain Res. 1998 Feb 16; 784(1-2): 148-153.
PMID: 9518585; UI: 98186675.

 Beal MF, et al.           
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP)
induced loss of striatal dopamine and dopaminergic axons in aged mice.
Brain Res. 1998 Feb 2; 783(1): 109-114.
PMID: 9479058; UI: 98147979.

 Gonzalez-Hoyuela M, et al.           
[No title available].
Rev Neurol. 1998 Feb; 26(150): 204-207. Spanish.
PMID: 9563089; UI: 98224187.

 Manfredi L, et al.           
Increased cortical inhibition induced by apomorphine in patients with
Parkinson's disease.
Neurophysiol Clin. 1998 Feb; 28(1): 31-38.
PMID: 9562997; UI: 98224094.

 Maertens de Noordhout A.           
[No title available].
Neurophysiol Clin. 1998 Feb; 28(1): 9-30. French.
PMID: 9562996; UI: 98224093.

 Navarro JA, et al.           
Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's
disease.
J Neurol Sci. 1998 Feb 18; 155(1): 92-94.
PMID: 9562329; UI: 98220798.

 Yoshita M.           
Differentiation of idiopathic Parkinson's disease from striatonigral
degeneration and progressive supranuclear palsy using iodine-123 meta-
iodobenzylguanidine myocardial scintigraphy.
J Neurol Sci. 1998 Feb 18; 155(1): 60-67.
PMID: 9562324; UI: 98220793.

 Turgut M, et al.           
Asymmetry of sympathetic activity in a rat model of Parkinson's disease
induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and
biochemical changes.
Res Exp Med (Berl). 1998; 197(5): 281-292.
PMID: 9561558; UI: 98222343.

 Kitada T, et al.           
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
Nature. 1998 Apr 9; 392(6676): 605-608.
PMID: 9560156; UI: 98219084.

 Nussbaum RL.           
Putting the parkin into Parkinson's.
Nature. 1998 Apr 9; 392(6676): 544-545. No abstract available.
PMID: 9560145; UI: 98219072.

 Finberg JP, et al.           
Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase
B inhibitor.
Neuroreport. 1998 Mar 9; 9(4): 703-707.
PMID: 9559942; UI: 98218869.

 Chamberlin E, et al.           
A glutamatergic model of ECT-induced memory dysfunction.
Harv Rev Psychiatry. 1998 Mar; 5(6): 307-317.
PMID: 9559349; UI: 98220103.

 De Rijk C, et al.           
[No title available].
Ned Tijdschr Geneeskd. 1998 Jan 3; 142(1): 27-31. Dutch.
PMID: 9556986; UI: 98217734.

 Schuurman PR, et al.           
[No title available].
Ned Tijdschr Geneeskd. 1998 Jan 3; 142(1): 10-14. Dutch.
PMID: 9556982; UI: 98217730.

 Adolphs R, et al.           
Intact recognition of facial emotion in Parkinson's disease.
Neuropsychology. 1998 Apr; 12(2): 253-258.
PMID: 9556771; UI: 98217517.

 Li RH, et al.           
Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell
encapsulation.
J Biomater Sci Polym Ed. 1998; 9(3): 239-258.
PMID: 9556760; UI: 98217506.

 Ikeda K, et al.           
[Atlas of cranial and spinal MRI--magnetic resonance imaging in carbon
monoxide poisoning and Parkinsonian syndrome].
No To Shinkei. 1998 Jan; 50(1): 86-87. Japanese. No abstract available.
PMID: 9556341; UI: 98216659.

 Melzi d'Eril G, et al.           
Total and non-protein-bound fractions of 3,4-dihydroxyphenylalanine.
Clin Chem. 1998 Apr; 44(4): 895. No abstract available.
PMID: 9554513; UI: 98213177.

 Sakamoto K, et al.           
Analysis of interaction of spinal and supraspinal reflex pathways involved in
physiological tremor.
Electromyogr Clin Neurophysiol. 1998 Mar; 38(2): 103-113.
PMID: 9553748; UI: 98214364.

 Choa RG.           
Reserve may be just another word for cowardice.
BMJ. 1998 Apr 4; 316(7137): 1089. No abstract available.
PMID: 9552918; UI: 98219738.

 Cumming P, et al.           
Compartmental analysis of dopa decarboxylation in living brain from dynamic
positron emission tomograms.
Synapse. 1998 May; 29(1): 37-61.
PMID: 9552174; UI: 98211903.

 Mayo JC, et al.           
Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells:
implications for Parkinson's disease.
J Pineal Res. 1998 Apr; 24(3): 179-192.
PMID: 9551855; UI: 98211580.

 Lezoualc'h F, et al.           
N-acetyl-serotonin (normelatonin) and melatonin protect neurons against
oxidative challenges and suppress the activity of the transcription factor NF-
kappaB.
J Pineal Res. 1998 Apr; 24(3): 168-178.
PMID: 9551854; UI: 98211579.

 Grace J, et al.           
Decline in cognitive function in Parkinson's disease may be due to dementia
with Lewy bodies.
BMJ. 1998 Mar 28; 316(7136): 1022. No abstract available.
PMID: 9550987; UI: 98212344.

 Fredholm BB, et al.           
Striatal adenosine A2A receptors--where are they? What do they do?
Trends Pharmacol Sci. 1998 Feb; 19(2): 46-48. No abstract available.
PMID: 9550940; UI: 98212297.

 Bootsma-Van Der Wiel A, et al.           
[No title available].
Ned Tijdschr Geneeskd. 1997 Nov 8; 141(45): 2170-2176. Dutch.
PMID: 9550798; UI: 98212155.

 Duursma SA, et al.           
[No title available].
Ned Tijdschr Geneeskd. 1997 Nov 8; 141(45): 2145-2147. Dutch.
PMID: 9550792; UI: 98212149.

 Kotter R, et al.           
Species-dependence and relationship of morphological and electrophysiological
properties in nigral compacta neurons.
Prog Neurobiol. 1998 Apr; 54(5): 619-632.
PMID: 9550193; UI: 98209563.

 [No authors listed]           
[Long-term strategy for the management of Parkinson patients].
Nervenarzt. 1998 Mar; 69(3 Suppl Langzeitst): 1-12. German. No abstract
available.
PMID: 9549716; UI: 98210885.

 Fowler JS, et al.           
Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B
(MAO B) inhibition.
J Addict Dis. 1998; 17(1): 23-34.
PMID: 9549600; UI: 98210769.

 Rascol O, et al.           
Cortical motor overactivation in parkinsonian patients with L-dopa-induced
peak-dose dyskinesia.
Brain. 1998 Mar; 121( Pt 3): 527-533.
PMID: 9549528; UI: 98210696.

 Platz T, et al.           
Training improves the speed of aimed movements in Parkinson's disease.
Brain. 1998 Mar; 121( Pt 3): 505-514.
PMID: 9549526; UI: 98210694.

 Krack P, et al.           
Subthalamic nucleus or internal pallidal stimulation in young onset
Parkinson's disease.
Brain. 1998 Mar; 121( Pt 3): 451-457.
PMID: 9549521; UI: 98210689.

 Praamstra P, et al.           
Reliance on external cues for movement initiation in Parkinson's disease.
Evidence from movement-related potentials.
Brain. 1998 Jan; 121( Pt 1): 167-177.
PMID: 9549497; UI: 98210665.

 Samuel M, et al.           
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI
location and complications.
Brain. 1998 Jan; 121( Pt 1): 59-75.
PMID: 9549488; UI: 98210656.

 Starr PA, et al.           
Deep brain stimulation for movement disorders.
Neurosurg Clin N Am. 1998 Apr; 9(2): 381-402. Review.
PMID: 9495900; UI: 98163479.

 Tasker RR.           
Ablative therapy for movement disorders. Does thalamotomy alter the course of
Parkinson's disease?
Neurosurg Clin N Am. 1998 Apr; 9(2): 375-380. Review.
PMID: 9495899; UI: 98163478.

 Alterman RL, et al.           
Pallidotomy technique and results: the New York University experience.
Neurosurg Clin N Am. 1998 Apr; 9(2): 337-343. Review.
PMID: 9495896; UI: 98163475.

 Lozano AM, et al.           
Pallidotomy for Parkinson's disease.
Neurosurg Clin N Am. 1998 Apr; 9(2): 325-336. Review.
PMID: 9495895; UI: 98163474.

 Perry VL, et al.           
Ablative therapy for movement disorders. Thalamotomy for Parkinson's disease.
Neurosurg Clin N Am. 1998 Apr; 9(2): 317-324. Review.
PMID: 9495894; UI: 98163473.

 Koller WC, et al.           
Surgical treatment options in Parkinson's disease.
Neurosurg Clin N Am. 1998 Apr; 9(2): 295-306. Review.
PMID: 9495892; UI: 98163471.

 Gildenberg PL.           
The history of surgery for movement disorders.
Neurosurg Clin N Am. 1998 Apr; 9(2): 283-294.
PMID: 9495891; UI: 98163470.

 Brooks DJ.           
Positron emission tomography studies in movement disorders.
Neurosurg Clin N Am. 1998 Apr; 9(2): 263-282. Review.
PMID: 9495890; UI: 98163469.

 Jellinger KA.           
Neuropathology of movement disorders.
Neurosurg Clin N Am. 1998 Apr; 9(2): 237-262. Review.
PMID: 9495889; UI: 98163468.

 Wichmann T, et al.           
Models of basal ganglia function and pathophysiology of movement disorders.
Neurosurg Clin N Am. 1998 Apr; 9(2): 223-236. Review.
PMID: 9495888; UI: 98163467.

 Tief K, et al.           
New evidence for presence of tyrosinase in substantia nigra, forebrain and
midbrain.
Brain Res Mol Brain Res. 1998 Jan; 53(1-2): 307-310.
PMID: 9473705; UI: 98141916.

 Crocker SJ, et al.           
D1-Receptor-related priming is attenuated by antisense-meditated 'knockdown'
of fosB expression.
Brain Res Mol Brain Res. 1998 Jan; 53(1-2): 69-77.
PMID: 9473593; UI: 98141890.

janet paterson aka calendar control supervisor
51/10 - sinemet/selegiline/prozac - [log in to unmask]
quotations: http://newww.com/cgi-bin/do_cal?c:newvoice
pwp event calendar: http://newww.com/cgi-bin/do_cal?c:pwpc